Tag: HER2positive

CHAPEL HILL, NC—Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have found that measuring activation of immune-system B cells ...

SAN ANTONIO – Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine (T-DM1) ...

Barcelona, Spain: Patients with a type of breast cancer called HER2-positive are less likely to survive if their initial treatment ...

Published in Nature, results of the interim analysis show that this novel triplet combination markedly reduces tumor size, induces a ...

EMBARGOED TIPSHEET SABCS: Subgroup analysis of trastuzumab deruxtecan (T-DXd) shows ‘encouraging’ results in controlling stable brain metastases in HER2-positive metastatic ...

Reston, VA (September 28, 2021)—A promising radionuclide treatment may offer new therapeutic options for breast cancer patients, according to research ...